Marksans Pharma recommended @ Rs.4 on 23rd March 2013. ( Recommendation link HERE ) .Currently stock is trading above Rs.17 ,an appreciation of whopping 300 % in less than 10 months.Recently management indicated their confidence to reduce the balance FCCB obligation substantially in next couple of years. Those interested to take some risk can still HOLD the stock.
0 comments:
Post a Comment